Case Page

 

Case Status:    DISMISSED    
On or around 07/20/2018 (Notice of voluntarily dismissal)

Filing Date: March 06, 2018

BioCryst Pharmaceuticals, Inc. ("BCRX") designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases.

According to the Complaint, on January 21, 2018, the merger agreement and the voting and support agreements were executed by Idera Pharmaceuticals, Inc. ("IDRA") and BCRX. The transaction was announced by joint press release on the morning of January 22, 2018.

On February 27, 2018, Defendants filed a Form S-4 Registration Statement (the “Registration Statement”) with the United States Securities and Exchange Commission in connection with the Proposed Mergers. The Complaint alleges that the Registration Statement fails to provide material information regarding the Proposed Mergers.

This case was voluntarily dismissed on July 20, 2018.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: BCRX
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Delaware
DOCKET #: 18-CV-00358
JUDGE: Hon. Leonard P. Stark
DATE FILED: 03/06/2018
CLASS PERIOD START: 01/22/2018
CLASS PERIOD END: 03/06/2018
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Gainey McKenna & Egleston
    440 Park Avenue South, 5th Floor, Gainey McKenna & Egleston, NY 10016
    212.983.1300 212.983.0380 ·
  2. O'Kelly Ernst & Joyce, LLC
    901 N. Market Street, Suite 1000, O'Kelly Ernst & Joyce, LLC, DE
    ·
No Document Title Filing Date
—Reference Complaint Complaint Related Data is not available
—Related District Court Filings Data is not available